Literature DB >> 19783448

Synthesis and evaluation of non-hydrolyzable D-mannose 6-phosphate surrogates reveal 6-deoxy-6-dicarboxymethyl-D-mannose as a new strong inhibitor of phosphomannose isomerases.

Johanna Foret1, Benoit de Courcy, Nohad Gresh, Jean-Philip Piquemal, Laurent Salmon.   

Abstract

Non-hydrolyzable d-mannose 6-phosphate analogues in which the phosphate group was replaced by a phosphonomethyl, a dicarboxymethyl, or a carboxymethyl group were synthesized and kinetically evaluated as substrate analogues acting as potential inhibitors of type I phosphomannose isomerases (PMIs) from Saccharomyces cerevisiae and Escherichia coli. While 6-deoxy-6-phosphonomethyl-d-mannose and 6-deoxy-6-carboxymethyl-D-mannose did not inhibit the enzymes significantly, 6-deoxy-6-dicarboxymethyl-D-mannose appeared as a new strong competitive inhibitor of both S. cerevisiae and E. coli PMIs with K(m)/K(i) ratios of 28 and 8, respectively. We thus report the first malonate-based inhibitor of an aldose-ketose isomerase to date. Phosphonomethyl mimics of the 1,2-cis-enediolate high-energy intermediate postulated for the isomerization reaction catalyzed by PMIs were also synthesized but behave as poor inhibitors of PMIs. A polarizable molecular mechanics (SIBFA) study was performed on the complexes of d-mannose 6-phosphate and two of its analogues with PMI from Candida albicans, an enzyme involved in yeast infection homologous to S. cerevisiae and E. coli PMIs. It shows that effective binding to the catalytic site occurs with retention of the Zn(II)-bound water molecule. Thus the binding of the hydroxyl group on C1 of the ligand to Zn(II) should be water-mediated. The kinetic study reported here also suggests the dianionic character of the phosphate surrogate as a likely essential parameter for strong binding of the inhibitor to the enzyme active site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19783448     DOI: 10.1016/j.bmc.2009.09.005

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

Review 1.  The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases.

Authors:  Minying Cai; Victor J Hruby
Journal:  Curr Protein Pept Sci       Date:  2016       Impact factor: 3.272

2.  Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.

Authors:  Russell Dahl; Yalda Bravo; Vandana Sharma; Mie Ichikawa; Raveendra-Panickar Dhanya; Michael Hedrick; Brock Brown; Justin Rascon; Michael Vicchiarelli; Arianna Mangravita-Novo; Li Yang; Derek Stonich; Ying Su; Layton H Smith; Eduard Sergienko; Hudson H Freeze; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2011-05-03       Impact factor: 7.446

3.  In silico prediction of antimalarial drug target candidates.

Authors:  Philipp Ludin; Ben Woodcroft; Stuart A Ralph; Pascal Mäser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-07-17       Impact factor: 4.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.